Bone fluoride levels are not associated with osteosarcoma: Study

NewsGuard 100/100 Score

A new study in the Journal of Dental Research finds bone fluoride levels are not associated with osteosarcoma, a rare bone cancer more prevalent in males.

A team of researchers from Harvard University, the Medical College of Georgia and the National Cancer Institute analyzed hundreds of bone samples from nine hospitals over an eight-year period from patients with osteosarcoma and a control group to measure fluoride levels in the bone.

Considered the most extensive study to date that examines a potential association between fluoride levels in bone and osteosarcoma, the results indicated no correlation. Three branches of the National Institutes of Health were involved in the study. The National Cancer Institute (NCI) approved the design of the study, and funding for the research was provided by the NCI, the National Institute of Environmental Health Sciences, and the National Institute of Dental and Craniofacial Research.

"As a science-based profession, we must always examine new evidence and consider it along with existing science in order to evaluate guidelines and recommendations for patient care," states Raymond Gist, D.D.S., president of the American Dental Association (ADA).

"This new study adds to an already strong base of scientific evidence that fluoride is safe and effective at preventing cavities," Dr. Gist states.

An inconclusive animal study conducted 20 years ago first raised the question of an association between fluoride and osteosarcoma. Since that time, other studies have examined the issue; however, this new study, using actual bone to measure fluoride levels in individuals with and without osteosarcoma, is considered by researchers to be the best science to date because a more accurate and reliable scientific method was used to measure exposure from all sources of fluoride.

"Tooth decay rates have declined dramatically over the past several decades, thanks in part to the use of fluoride," Dr. Gist states. "To help prevent cavities, the ADA continues to recommend brushing twice a day with fluoride toothpaste, flossing daily, eating a balanced diet and visiting your dentist regularly."

Comments

  1. nyscof nyscof United States says:

    The main author of this study, Chester Douglass "has written reviews of the literature for several companies that sell, reimburse for, or do research on preventive dentistry products, most notably GlaxoSmithKline, Colgate-Palmolive, Dentsply, Quintile, Delta Dental Plans, and the United States Public health Service (USPHS)," according to the acknowledgment section of this study.

    C Hayes (co-author) "has done limited consulting with Procter & Gamble."

    This study has some major flaws. Here are three: 1) The controls had bone cancer also 2) The Controls were much older than the Cases (Median age 41 and 17.6 years-old, respectively (Fluoride builds up in bone with age) 3) Osteosarcoma occurs more frequently in teenage boys. In the Douglass study 53% of the cases were male but 71% of the controls were male
    80% of the cases were 0-29 years old but only 41% of the controls were 0 – 29 years old

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rice scientists identify promising new immunological pathway to treat breast cancer bone metastases